This aligns with what we know about the branded products
SURPASS-1: Over 4,500 participants
This week is about showing up and getting comfortable, not setting records
December 10, 2025: People Who Lost Vision After Taking Ozempic May Be Able to Join Group Lawsuit Last week, the Judicial Panel on Multidistrict Litigation (JMPML) held a session to determine if a group lawsuit will be created for people who have GLP-1-related vision loss
The results are summarized below: Source: SURPASS-3 MRI substudy, 52-week treatment results Further analysis showed that compared to a virtual control group matched for gender and BMI, the tirzepatide-treated group exhibited significantly decreased standardized scores for visceral fat and liver fat, while subcutaneous fat scores actually increased-researchers believe this may reflect a shift toward a more balanced fat distribution pattern, prioritizing the reduction of metabolically harmful visceral and liver fat
Rates moved within a single day, so verify current pricing on the brand's own site before committing
